journal article·2024-05-13Open access

Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions

Hye Kyu Choi, Meizi Chen, Li Ling Goldston, Ki-Bum Lee

Nano Convergence· Volume 11· Issue 1

Abstract

Abstract Central Nervous System (CNS) disorders represent a profound public health challenge that affects millions of people around the world. Diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and traumatic brain injury (TBI) exemplify the complexities and diversities that complicate their early detection and the development of effective treatments. Amid these challenges, the emergence of nanotechnology and extracellular vesicles (EVs) signals a new dawn for treating and diagnosing CNS ailments. EVs are cellularly derived lipid bilayer nanosized particles that are pivotal in intercellular communication within the CNS and have the potential to revolutionize targeted therapeutic delivery and the identification of novel biomarkers. Integrating EVs with nanotechnology amplifies their diagnostic and therapeutic capabilities, opening new avenues for managing CNS diseases. This review focuses on examining the fascinating interplay between EVs and nanotechnology in CNS theranostics. Through highlighting the remarkable advancements and unique methodologies, we aim to offer valuable perspectives on how these approaches can bring about a revolutionary change in disease management. The objective is to harness the distinctive attributes of EVs and nanotechnology to forge personalized, efficient interventions for CNS disorders, thereby providing a beacon of hope for affected individuals. In short, the confluence of EVs and nanotechnology heralds a promising frontier for targeted and impactful treatments against CNS diseases, which continue to pose significant public health challenges. By focusing on personalized and powerful diagnostic and therapeutic methods, we might improve the quality of patients.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Advanced Nanomaterials in Catalysis · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. W.H. Organization, (2021)
2. S. Spudich, A. Nath, Science. 375(6578), 267–269 (2022)10.1126/science.abm2052 ↗
3. P. Scheltens, B. De Strooper, M. Kivipelto, H. Holstege, G. Chételat, C.E. Teunissen, J. Cummings, W.M. van der Flier, Lancet. 397(10284), 1577–1590 (2021)10.1016/S0140-6736(20)32205-4 ↗
4. A.A. Tahami Monfared, M.J. Byrnes, L.A. White, Q. Zhang, Neurol. Ther. 11(2), 553–569 (2022)10.1007/s40120-022-00338-8 ↗
5. B.R. Bloem, M.S. Okun, C. Klein, Lancet. 397(10291), 2284–2303 (2021)10.1016/S0140-6736(21)00218-X ↗
6. E. Tolosa, A. Garrido, S.W. Scholz, W. Poewe, Lancet Neurol. 20(5), 385–397 (2021)10.1016/S1474-4422(21)00030-2 ↗
7. K. Thapa, H. Khan, T.G. Singh, A. Kaur, J. Mol. Neurosci. 71(9), 1725–1742 (2021)10.1007/s12031-021-01841-7 ↗
8. S.A. Quadri et al., Neurosurg. Rev. 43(2), 425–441 (2020)10.1007/s10143-018-1008-3 ↗
9. D.M. 3 Wilson rd, M.R. Cookson, L. Van Den Bosch, H. Zetterberg, D.M. Holtzman, I. Dewachter, Cell. 186(4), 693–714 (2023)10.1016/j.cell.2022.12.032 ↗
10. A.D. Greenhalgh, S. David, F.C. Bennett, Nat. Rev. Neurosci. 21(3), 139–152 (2020)10.1038/s41583-020-0263-9 ↗
11. M.A. Myszczynska, P.N. Ojamies, A.M.B. Lacoste, D. Neil, A. Saffari, R. Mead, G.M. Hautbergue, J.D. Holbrook, L. Ferraiuolo, Nat. Rev. Neurol. 16(8), 440–456 (2020)10.1038/s41582-020-0377-8 ↗
12. S. Mukherjee, V.S. Madamsetty, D. Bhattacharya, S.R. Chowdhury, M.K. Paul, A. Mukherjee, Adv. Funct. Mater. 30(35), 2003054 (2020)10.1002/adfm.202003054 ↗
13. A.I.R. Maas et al., Lancet Neurol. 21(11), 1004–1060 (2022)10.1016/S1474-4422(22)00309-X ↗
14. Y. Fan, Z. Chen, M. Zhang, J. Transl Med. 20(1), 291 (2022)10.1186/s12967-022-03493-6 ↗
15. O. Hansson, Nat. Med. 27(6), 954–963 (2021)10.1038/s41591-021-01382-x ↗
16. P. Masrori, P. Van Damme, Eur. J. Neurol. 27(10), 1918–1929 (2020)10.1111/ene.14393 ↗
17. M. Kenigsbuch et al., Nat. Neurosci. 25(7), 876–886 (2022)10.1038/s41593-022-01104-7 ↗
18. J. Bryois et al., Nat. Genet. 52(5), 482– (2020)10.1038/s41588-020-0610-9 ↗
19. P.N.E. Young et al., Alzheimers Res. Ther. 12(1), 49 (2020)10.1186/s13195-020-00612-7 ↗
20. N. Swaddiwudhipong, D.J. Whiteside, F.H. Hezemans, D. Street, J.B. Rowe, T. Rittman, Alzheimers Dement. 19(5), 1752–1763 (2023)10.1002/alz.12802 ↗
21. D. Berg, P. Borghammer, S.M. Fereshtehnejad, S. Heinzel, J. Horsager, E. Schaeffer, R.B. Postuma, Nat. Rev. Neurol. 17(6), 349–361 (2021)10.1038/s41582-021-00486-9 ↗
22. B. Lam, M. Masellis, M. Freedman, D.T. Stuss, S.E. Black, Alzheimers Res. Ther. 5(1), 1 (2013)10.1186/alzrt155 ↗
23. D. Furtado, M. Bjornmalm, S. Ayton, A.I. Bush, K. Kempe, F. Caruso, Adv. Mater. 30(46), e1801362 (2018)10.1002/adma.201801362 ↗
24. R. Pandit, L. Chen, J. Gotz, Adv. Drug Deliv Rev. 165–166, 1–14 (2020)10.1016/j.addr.2019.11.009 ↗
25. S. Ramanathan, G. Archunan, M. Sivakumar, S. Tamil Selvan, A.L. Fred, S. Kumar, B. Gulyas, P. Padmanabhan, Int. J. Nanomed. 13(null), 5561–5576 (2018)10.2147/IJN.S149022 ↗
26. J. Liu, J. Li, S. Zhang, M. Ding, N. Yu, J. Li, X. Wang, Z. Li, Nano Converg. 9(1), 13 (2022)10.1186/s40580-022-00304-y ↗
27. Z. Cao, J. Liu, X. Yang, Exploration n/a(n/a), 20230037 (2024)
28. H. Lei, Z. Pei, C. Jiang, L. Cheng, Explor. (Beijing). 3(5), 20220001 (2023)
29. M.Z. Chen, X.W. Cao, K. Chang, H.H. Xiang, R. Wang, Electrochim. Acta 368 (2021)10.1016/j.electacta.2020.137603 ↗
30. B. Conklin, B.M. Conley, Y. Hou, M. Chen, K.B. Lee, Adv. Drug Deliv Rev. 192, 114636 (2023)10.1016/j.addr.2022.114636 ↗
31. S. Dadkan, M. Khakbiz, L. Ghazanfari, M.Z. Chen, K.B. Lee, J. Mol. Liq 365 (2022)10.1016/j.molliq.2022.119824 ↗
32. V. Biju, Chem. Soc. Rev. 43(3), 744–764 (2014)10.1039/C3CS60273G ↗
33. M. Saeedi, M. Eslamifar, K. Khezri, S.M. Dizaj, Biomed. Pharmacother. 111, 666–675 (2019)10.1016/j.biopha.2018.12.133 ↗
34. S. Masoudi Asil, J. Ahlawat, G. Guillama, Barroso, M. Narayan, Biomater. Sci. 8(15), 4109–4128 (2020)10.1039/D0BM00809E ↗
35. J.H. Choi, H.K. Choi, K.B. Lee, Adv. Funct. Mater. 33(46), 2304382 (2023)10.1002/adfm.202304382 ↗
36. E.S. Ereifej, M.M. Cheng, G. Mao, P.J. VandeVord, J. Neurosci. Methods. 217(1–2), 17–25 (2013)10.1016/j.jneumeth.2013.04.023 ↗
37. M. Tkach, C. Thery, Cell. 164(6), 1226–1232 (2016)10.1016/j.cell.2016.01.043 ↗
38. P.D. Robbins, A.E. Morelli, Nat. Rev. Immunol. 14(3), 195–208 (2014)10.1038/nri3622 ↗
39. J.C. Akers, D. Gonda, R. Kim, B.S. Carter, C.C. Chen, J. Neurooncol. 113(1), 1–11 (2013)10.1007/s11060-013-1084-8 ↗
40. R. Kalluri, V.S. LeBleu, Science. 367(6478), eaau6977 (2020)10.1126/science.aau6977 ↗
41. E.T. Kavalali, Nat. Rev. Neurosci. 16(1), 5–16 (2015)10.1038/nrn3875 ↗
42. V. Budnik, C. Ruiz-Canada, F. Wendler, Nat. Rev. Neurosci. 17(3), 160–172 (2016)10.1038/nrn.2015.29 ↗
43. G. Turturici, R. Tinnirello, G. Sconzo, F. Geraci, Am. J. Physiol. Cell. Physiol. 306(7), C621–633 (2014)10.1152/ajpcell.00228.2013 ↗
44. G. van Niel, D.R.F. Carter, A. Clayton, D.W. Lambert, G. Raposo, P. Vader, Nat. Rev. Mol. Cell. Biol. 23(5), 369–382 (2022)10.1038/s41580-022-00460-3 ↗
45. A.G. Thompson, E. Gray, S.M. Heman-Ackah, I. Mager, K. Talbot, S.E. Andaloussi, M.J. Wood, M.R. Turner, Nat. Rev. Neurol. 12(6), 346–357 (2016)10.1038/nrneurol.2016.68 ↗
46. S.G. Kang et al., Nano Converg. 10(1), 5 (2023)10.1186/s40580-022-00350-6 ↗
47. J.Y. Kim, W.K. Rhim, S.G. Cha, J. Woo, J.Y. Lee, C.G. Park, D.K. Han, Nano Converg. 9(1), 57 (2022)10.1186/s40580-022-00349-z ↗
48. F.M. Filannino, M.A. Panaro, T. Benameur, I. Pizzolorusso, C. Porro, Int. J. Mol. Sci. 25(3) (2024)10.3390/ijms25031629 ↗
49. M. Guo, L. Wang, Z. Yin, F. Chen, P. Lei, Biomed. Pharmacother. 167, 115407 (2023)10.1016/j.biopha.2023.115407 ↗
50. R. Wang, X. Wang, Y. Zhang, H. Zhao, J. Cui, J. Li, L. Di, J. Control Release. 341, 844–868 (2022)10.1016/j.jconrel.2021.12.024 ↗
51. T. Tian, S. Qiao, B.A. Tannous, ACS Appl. Mater. Interfaces. 15(1), 182–199 (2023)10.1021/acsami.2c07981 ↗
52. S. Malik, K. Muhammad, Y. Waheed, Molecules 28(18) (2023)10.3390/molecules28186624 ↗
53. N. Desai, AAPS J. 14(2), 282–295 (2012)10.1208/s12248-012-9339-4 ↗
54. M. Shi, L. Sheng, T. Stewart, C.P. Zabetian, J. Zhang, Prog Neurobiol. 175, 96–106 (2019)10.1016/j.pneurobio.2019.01.005 ↗
55. J. Saint-Pol, F. Gosselet, S. Duban-Deweer, G. Pottiez, Y. Karamanos, Cells 9(4) (2020)10.3390/cells9040851 ↗
56. J. Matsumoto, T. Stewart, W.A. Banks, J. Zhang, Curr. Pharm. Des. 23(40), 6206–6214 (2017)10.2174/1381612823666170913164738 ↗
57. W.A. Banks, P. Sharma, K.M. Bullock, K.M. Hansen, N. Ludwig, T.L. Whiteside, Int. J. Mol. Sci. 21(12) (2020)10.3390/ijms21124407 ↗
58. D. Bingxue, L. Wenchao, B. Xing, in Handbook of Chemical Biology of Nucleic Acids, edited by N. SugimotoSpringer Nature Singapore, Singapore, (2022), pp. 1–2210.1007/978-981-16-1313-5_74-1 ↗
59. Y. Ding, Y. Wang, Q. Hu, Explor. (Beijing). 2(3), 20210106 (2022)
60. B.N. Dugger, D.W. Dickson, Cold Spring Harb Perspect. Biol. 9(7), a028035 (2017)10.1101/cshperspect.a028035 ↗
61. A.P. Porsteinsson, R.S. Isaacson, S. Knox, M.N. Sabbagh, I. Rubino, J. Prev. Alzheimers Dis. 8(3), 371–386 (2021)
62. S. Rastogi, V. Sharma, P.S. Bharti, K. Rani, G.P. Modi, F. Nikolajeff, S. Kumar, Int. J. Mol. Sci. 22(1), 440 (2021)10.3390/ijms22010440 ↗
63. L. Gu, Z. Guo, J. Neurochem. 126(3), 305–311 (2013)10.1111/jnc.12202 ↗
64. C. Bellenguez, B. Grenier-Boley, J.C. Lambert, Curr. Opin. Neurobiol. 61, 40–48 (2020)10.1016/j.conb.2019.11.024 ↗
65. M. Gatz, C.A. Reynolds, L. Fratiglioni, B. Johansson, J.A. Mortimer, S. Berg, A. Fiske, N.L. Pedersen, Arch. Gen. Psychiatry. 63(2), 168–174 (2006)10.1001/archpsyc.63.2.168 ↗
66. C.M. Karch, C. Cruchaga, A.M. Goate, Neuron. 83(1), 11–26 (2014)10.1016/j.neuron.2014.05.041 ↗
67. P. Buchhave, L. Minthon, H. Zetterberg, Å.K. Wallin, K. Blennow, O. Hansson, Arch. Gen. Psychiatry. 69(1), 98–106 (2012)10.1001/archgenpsychiatry.2011.155 ↗
68. V.L. Villemagne et al., Lancet Neurol. 12(4), 357–367 (2013)10.1016/S1474-4422(13)70044-9 ↗
69. M.A. DeTure, D.W. Dickson, Mol. Neurodegener. 14(1), 32 (2019)10.1186/s13024-019-0333-5 ↗
70. J. Weller, A. Budson, F1000Res 7 (2018)10.12688/f1000research.14506.1 ↗
71. O.H. Lesman-Segev et al., Ann. Neurol. 89(2), 389–401 (2021)10.1002/ana.25968 ↗
72. P. Bhutani, G. Joshi, N. Raja, N. Bachhav, P.K. Rajanna, H. Bhutani, A.T. Paul, R. Kumar, J. Med. Chem. 64(5), 2339–2381 (2021)10.1021/acs.jmedchem.0c01786 ↗
73. G. Marucci, M. Buccioni, D.D. Ben, C. Lambertucci, R. Volpini, F. Amenta, Neuropharmacology. 190, 108352 (2021)10.1016/j.neuropharm.2020.108352 ↗
74. T. Athar, K. Al, Balushi, S.A. Khan, Mol. Biol. Rep. 48(7), 5629–5645 (2021)10.1007/s11033-021-06512-9 ↗
75. M. Vaz, S. Silvestre, Eur. J. Pharmacol. 887, 173554 (2020)10.1016/j.ejphar.2020.173554 ↗
76. R. Balestrino, A. Schapira, Eur. J. Neurol. 27(1), 27–42 (2020)10.1111/ene.14108 ↗
77. J. Blesa, G. Foffani, B. Dehay, E. Bezard, J.A. Obeso, Nat. Rev. Neurosci. 23(2), 115–128 (2022)10.1038/s41583-021-00542-9 ↗
78. C. Blauwendraat, M.A. Nalls, A.B. Singleton, Lancet Neurol. 19(2), 170–178 (2020)10.1016/S1474-4422(19)30287-X ↗
79. M.J. Armstrong, M.S. Okun, JAMA 323(6), 548–560 (2020)10.1001/jama.2019.22360 ↗
80. O. Hardiman, A. Al-Chalabi, A. Chio, E.M. Corr, G. Logroscino, W. Robberecht, P.J. Shaw, Z. Simmons, L.H. Van Den Berg, Nat. Reviews Disease Primers. 3(1), 1–19 (2017)
81. H. Ilieva, M. Vullaganti, J. Kwan, BMJ 383, e075037 (2023)10.1136/bmj-2023-075037 ↗
82. P. McColgan, S.J. Tabrizi, Eur. J. Neurol. 25(1), 24–34 (2018)10.1111/ene.13413 ↗
83. S.J. Tabrizi et al., Lancet Neurol. 21(7), 645–658 (2022)10.1016/S1474-4422(22)00121-1 ↗
84. J.H. Badhiwala, J.R. Wilson, M.G. Fehlings, Lancet Neurol. 18(1), 24–25 (2019)10.1016/S1474-4422(18)30444-7 ↗
85. A.I.R. Maas et al., Lancet Neurol. 16(12), 987–1048 (2017)10.1016/S1474-4422(17)30371-X ↗
86. M. Majdan, D. Plancikova, A. Maas, S. Polinder, V. Feigin, A. Theadom, M. Rusnak, A. Brazinova, J. Haagsma, PLoS Med. 14(7), e1002331 (2017)10.1371/journal.pmed.1002331 ↗
87. B. Te Ao et al., Neuroepidemiology. 44(4), 255–261 (2015)10.1159/000431043 ↗
88. A.A. Ladak, S.A. Enam, M.T. Ibrahim, World Neurosurg. 131, 126–132 (2019)10.1016/j.wneu.2019.07.039 ↗
89. S.Y. Ng, A.Y.W. Lee, Front. Cell. Neurosci. 13, 528 (2019)10.3389/fncel.2019.00528 ↗
90. I.J. Reynolds, T.G. Hastings, J. Neurosci. 15(5 Pt 1), 3318–3327 (1995)10.1523/JNEUROSCI.15-05-03318.1995 ↗
91. C.D. Sharp, J. Houghton, J.W. Elrod, A. Warren, T.H. Jackson, A. Jawahar, A. Nanda, A. Minagar, J.S. Alexander, Am J Physiol Heart Circ Physiol 288(4), H1893-1899 (2005)10.1152/ajpheart.01110.2003 ↗
92. O. Tenovuo, R. Diaz-Arrastia, L.E. Goldstein, D.J. Sharp, J. van der Naalt, N.D. Zasler, J. Clin. Med. 10(1) (2021)10.3390/jcm10010148 ↗
93. K. Dams-O’Connor et al., J. Neurotrauma. 30(24), 2014–2020 (2013)10.1089/neu.2013.3049 ↗
94. J.J. Kim, A.D. Gean, Neurotherapeutics. 8(1), 39–53 (2011)10.1007/s13311-010-0003-3 ↗
95. M. Galgano, G. Toshkezi, X. Qiu, T. Russell, L. Chin, L.R. Zhao, Cell. Transpl. 26(7), 1118–1130 (2017)10.1177/0963689717714102 ↗
96. C.S. Ahuja, J.R. Wilson, S. Nori, M. Kotter, C. Druschel, A. Curt, M.G. Fehlings, Nat. Reviews Disease Primers. 3(1), 1–21 (2017)
97. A. Anjum, M.D. Yazid, M. Fauzi Daud, J. Idris, A.M.H. Ng, A. Selvi Naicker, O.H.R. Ismail, R.K. Athi, Kumar, Y. Lokanathan, Int. J. Mol. Sci. 21(20), 7533 (2020)10.3390/ijms21207533 ↗
98. V.L. Feigin, M. Brainin, B. Norrving, S. Martins, R.L. Sacco, W. Hacke, M. Fisher, J. Pandian, P. Lindsay, Int. J. Stroke. 17(1), 18–29 (2022)10.1177/17474930211065917 ↗
99. M.S. Phipps, C.A. Cronin, BMJ. 368, l6983 (2020)10.1136/bmj.l6983 ↗
100. S.K. Feske, Am. J. Med. 134(12), 1457–1464 (2021)10.1016/j.amjmed.2021.07.027 ↗